ISSN: 2161-0460

Journal de la maladie d'Alzheimer et du parkinsonisme

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Indexé dans
  • Index Copernic
  • Google Scholar
  • Sherpa Roméo
  • Ouvrir la porte J
  • JournalSeek de génamique
  • Clés académiques
  • JournalTOC
  • Infrastructure nationale du savoir de Chine (CNKI)
  • Bibliothèque de revues électroniques
  • Recherche de référence
  • Université Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Catalogue en ligne SWB
  • Bibliothèque virtuelle de biologie (vifabio)
  • Publons
  • Fondation genevoise pour l'enseignement et la recherche médicale
  • Euro Pub
  • ICMJE
Partager cette page

Abstrait

Can the Associated Use of Negative Pressure and Laser Therapy Be A New and Efficient Treatment for Parkinson's Pain? A Comparative Study

Patrícia Eriko Tamae, Adriana Vital Dos Santos, Michelle Luise de Souza Simão, Ana Carolina Negraes Canelada, Kely Regina Zampieri, Tânia Vital Dos Santos, Antonio Eduardo de Aquino Junior and Vanderlei Salvador Bagnato

Parkinson's disease is a chronic, progressive, neurodegenerative disease of the central nervous system, being the second most frequent movement disorder, affecting about 1% to 3% of the population aged over 60 years. Parkinson´s disease is characterized by three basic symptoms: Tremor, stiffness and bradykinesia. This study promotes the analysis of the combination of Laser Therapy with Vacuum Therapy which creates adequate conditions for a synergic effect of both together. 18 patients were selected, subjects with idiopathic Parkinson's Disease, diagnosed by a neurologist, of both genders, aged between 30 and 80 years, who use drugs to control Parkinson's disease and were classified according to reports of muscle pain and stiffness. The patients were divided into 3 groups (n=6): Experimental group (GE, n=6), control group 1 (GC1, n=6) and control group 2 (GC2, n=6). The analyses were realized in relation to visual analogue scale and quality of life. The results found point to a better effect for quality of life and pain through the synergistic action of therapies (Group Experimental). In conclusion, it is possible to affirm that the synergy of therapies (Laser and Vacuum Therapy) can improve the quality of life of the patient affected by Parkinson's disease.